Search

Drug Profiles Catalysts Company Profiles Impact Events Target
Indication Trials KOL Insight Special Reports All

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
3/6/15 Novartis (NVS) NVA237 for Chronic Obstructive Pulmonary Disease (COPD) Subscribers Only Subscribers Only Subscribers Only
3/6/15 Catalyst Biosciences (CBIO) TC-6499 for Diabetic Gastroparesis Subscribers Only Subscribers Only Subscribers Only
3/6/15 Astellas (4503:JP) Cresemba for Fungal Infections - Systemic Subscribers Only Subscribers Only Subscribers Only
3/6/15 Novartis (NVS) Zarxio for Neutropenia / Leukopenia Subscribers Only Subscribers Only Subscribers Only
3/5/15 ViroMed (084990:KS) VM202 for Diabetic Peripheral Neuropathy (DPN) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
03/07/15 Subscribers Only Subscribers Only Trial Data - Updated Results
03/07/15 Subscribers Only Subscribers Only Trial Data - Top-Line Results
Now - 03/08/15 Subscribers Only Subscribers Only Trial Data - Top-Line Results
03/09/15 Subscribers Only Subscribers Only Regulatory - FDA Advisory Panel Meeting
03/09/15 Subscribers Only Subscribers Only Company - Analyst/R&D Update